Skip to content
Cancer Matters Home Issues & Perspectives Platz Named Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention

Platz Named Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention

A national publication on cancer causes, prevention, detection and survivorship will have a Johns Hopkins cancer epidemiologist at the helm for 2019.

Elizabeth Platz, M.P.H., Sc.D, is the co-leader for cancer prevention and control at the Johns Hopkins Kimmel Cancer Center. She was named as editor-in-chief of Cancer Epidemiology, Biomarkers & Prevention (CEBP), one of eight journals published by the American Association for Cancer Research (AACR).

Platz is a cancer epidemiologist, whose research on prostate and colon cancers sits at the interface between epidemiology and basic science. She conducts her multidisciplinary work with an eye toward identifying strategies to prevent the development or progression of cancer.

Elizabeth Platz, Sc.D., M.P.H., co-leader for cancer prevention and control at the Johns Hopkins Kimmel Cancer Center

Platz has been an active member of the AACR since 1998, having served as an editorial board member of the AACR journal Cancer Research and, more recently, as a senior editor of Cancer Epidemiology, Biomarkers & Prevention before being named editor-in-chief. She has served on scientific program committees for many AACR meetings, including the AACR Annual Meeting.

“As an editor, I have always pursued excellence, including ensuring the quality of reviews provided to authors and the timeliness of these reviews,” Platz said. “Editorial excellence benefits authors, CEBP, the AACR, and the entire epidemiologic community.”

“The American Association for Cancer Research is happy to welcome Dr. Platz as editor-in-chief of Cancer Epidemiology, Biomarkers & Prevention,” said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR. “With more than 20 years of experience in the field of cancer epidemiology, Platz has worked extensively to integrate epidemiology and basic science to inform prevention and treatment strategies. Her vision for the journal will build on its past successes and continue to advance its reputation as the top cancer research journal in the area of population science.”